Chicago, IL, United States of America

Lifang Yu

This inventor holds 1 USPTO granted patent and 2 published patent applications. Top assignee: Hoffmann-La Roche Inc.. Active years: 2014.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Lifang Yu. Retrieved from https://idiyas.com/inventor/lifang-yu-bwvmfv00

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 1 

Average Co-Inventor Count = 8.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2014

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Lifang Yu - Innovator in Alkene Oxindole Derivatives

Introduction

Lifang Yu is a notable inventor based in Chicago, IL (US). She has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that target AMPK regulation. Her innovative work has the potential to impact the treatment and prophylaxis of various diseases.

Latest Patents

Lifang Yu holds 1 patent for her invention related to alkene oxindole derivatives. The patent provides compounds of formula (I), along with pharmaceutically acceptable salts, which are useful in addressing health issues associated with AMPK regulation.

Career Highlights

Lifang Yu is currently employed at Hoffmann-La Roche Inc., a leading company in the pharmaceutical industry. Her role involves research and development, where she applies her expertise to create innovative solutions for healthcare challenges.

Collaborations

Throughout her career, Lifang has collaborated with talented individuals such as Li Chen and Lichun Feng. These partnerships have fostered a creative environment that enhances the development of groundbreaking pharmaceutical compounds.

Conclusion

Lifang Yu's contributions to the field of pharmaceuticals through her innovative patents and collaborations highlight her role as a key inventor in the industry. Her work continues to pave the way for advancements in medical treatments.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…